While the debate on employing anti-VEGF therapy to manage cerebral edema in stroke and HI patients continues12,43–46, our results suggest that targeting this angiogenic pathway in HI patients may impede dura mater recovery and compromise its primary functions. Here, VEGFA is linked to edema.